White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study.

<h4>Background</h4>The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nancy Babio, Núria Ibarrola-Jurado, Mònica Bulló, Miguel Ángel Martínez-González, Julia Wärnberg, Itziar Salaverría, Manuel Ortega-Calvo, Ramón Estruch, Lluís Serra-Majem, Maria Isabel Covas, José Vicente Sorli, Jordi Salas-Salvadó, PREDIMED Study Investigators
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/f1f067a6591d409c90ac2c006058357c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!